Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |